Spots Global Cancer Trial Database for tumor progression
Every month we try and update this database with for tumor progression cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca | NCT03919292 | Solid Tumor, Ad... | Neratinib Divalproex Sodi... | 18 Years - | Virginia Commonwealth University | |
| Open-Label Study of TPI 287 for Patients With Metastatic Melanoma | NCT01340729 | Metastatic Mela... | TPI 287 | 15 Years - | M.D. Anderson Cancer Center | |
| Open-Label Study of TPI 287 for Patients With Metastatic Melanoma | NCT01340729 | Metastatic Mela... | TPI 287 | 15 Years - | M.D. Anderson Cancer Center | |
| The Effect of Intravenous Lidocaine on THBS2 and Angiogenic Factors Expression in Women Undergoing Cervical Cancer Surgery | NCT05560035 | Cervical Cancer Metastatic Canc... | Lidocaine Normal saline (... | 18 Years - 65 Years | General Hospital of Ningxia Medical University | |
| The Effect of Intravenous Lidocaine on THBS2 and Angiogenic Factors Expression in Women Undergoing Cervical Cancer Surgery | NCT05560035 | Cervical Cancer Metastatic Canc... | Lidocaine Normal saline (... | 18 Years - 65 Years | General Hospital of Ningxia Medical University | |
| Optimal EGFR TKIs Treatment Strategies for Lung Adenocarcinoma Harboring EGFR Exon 19 Deletion Variants | NCT04370860 | EGFR Exon 19 Mu... Tumor Progressi... | 20 Years - 90 Years | National Taiwan University Hospital | ||
| Sodium Selenite as a Cytotoxic Agent in Advanced Carcinoma | NCT01959438 | Malignant Tumor Treatment Resis... Tumor Progressi... | Sodium selenite... Sodium selenite | 18 Years - | Karolinska University Hospital | |
| Sodium Selenite as a Cytotoxic Agent in Advanced Carcinoma | NCT01959438 | Malignant Tumor Treatment Resis... Tumor Progressi... | Sodium selenite... Sodium selenite | 18 Years - | Karolinska University Hospital | |
| Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca | NCT03919292 | Solid Tumor, Ad... | Neratinib Divalproex Sodi... | 18 Years - | Virginia Commonwealth University | |
| Predictive Value of Human Microbiome and Serological Markers for Clinical Outcome of AIS With Active Cancer | NCT05553990 | Ischemic Stroke... Tumor Progressi... | intestinal flor... | 18 Years - 85 Years | Nanfang Hospital, Southern Medical University | |
| The Effect of Intravenous Lidocaine on THBS2 and Angiogenic Factors Expression in Women Undergoing Cervical Cancer Surgery | NCT05560035 | Cervical Cancer Metastatic Canc... | Lidocaine Normal saline (... | 18 Years - 65 Years | General Hospital of Ningxia Medical University | |
| Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma | NCT03727841 | Anaplastic Epen... Ependymoma Ependymomas | Marizomib | - | National Institutes of Health Clinical Center (CC) | |
| The Role of Protein Tyrosine Kinase 7 (PTK7) in Non-small Cell Lung Cancer | NCT04018183 | Tumor Progressi... | 20 Years - 90 Years | National Taiwan University Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
